Insider filing · NMRA
Robert A. Lenz
Head of R&D
profile →
Neumora Therapeutics, Inc.
NMRA · Healthcare · 7 filings in 24 months
ticker →
Robert A. Lenz sold $377K of Neumora Therapeutics (NMRA)
Executed Sep 12 2024, disclosed Sep 16 2024, 4 days later.
Value, as filed
$377K
32,948 sh × $11.43
Executed
Sep 12 2024
the trade date, as filed
Disclosed
Sep 16 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RLRobert A. Lenz (Head of R&D) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Neumora Therapeutics, Inc. (NMRA).
The name
NMRAHealthcare · Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, ne…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Robert A. Lenz in NMRA
NMRASALE
Neumora Therapeutics, Inc.
–8,260 sh · price not plausible
Exec Oct 10 2024
Filed Oct 11 2024 · 5:30 PM ET NMRASALE Neumora Therapeutics, Inc. $493K
41,464 sh across 2 lots
Exec Sep 17 2024
Filed Sep 19 2024 · 5:30 PM ET